Latest Insider Transactions at Avanos Medical, Inc. (AVNS)
This section provides a real-time view of insider transactions for Avanos Medical, Inc. (AVNS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AVANOS MEDICAL, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AVANOS MEDICAL, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Oct 29
2024
|
Michael Greiner Interim CEO |
BUY
Grant, award, or other acquisition
|
Direct |
44,189
+18.8%
|
-
|
Sep 05
2024
|
John Joseph Hurley Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,001
+23.73%
|
-
|
Jul 22
2024
|
Mojirade James SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
684
-0.96%
|
$14,364
$21.99 P/Share
|
Mar 18
2024
|
Kerr Holbrook SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,596
-2.02%
|
$68,324
$19.09 P/Share
|
Mar 18
2024
|
Kerr Holbrook SVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,531
+2.74%
|
-
|
Mar 18
2024
|
Michael Greiner Interim CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,005
-2.92%
|
$171,095
$19.09 P/Share
|
Mar 18
2024
|
Michael Greiner Interim CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,219
+2.64%
|
-
|
Mar 18
2024
|
Joseph Fralin Woody Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
33,765
-3.77%
|
$641,535
$19.09 P/Share
|
Mar 18
2024
|
Joseph Fralin Woody Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,821
+3.37%
|
-
|
Mar 14
2024
|
Michael Greiner Interim CEO |
SELL
Open market or private sale
|
Direct |
8,000
-0.85%
|
$152,000
$19.14 P/Share
|
Mar 11
2024
|
Julie Ann Shimer Director |
BUY
Open market or private purchase
|
Direct |
500
+0.99%
|
$9,500
$19.85 P/Share
|
Mar 06
2024
|
Kerr Holbrook SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,618
-2.91%
|
$49,742
$19.0 P/Share
|
Mar 06
2024
|
Kerr Holbrook SVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
36,573
+28.94%
|
$694,887
$19.14 P/Share
|
Mar 06
2024
|
Michael Greiner Interim CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,118
-3.11%
|
$97,242
$19.0 P/Share
|
Mar 06
2024
|
Michael Greiner Interim CEO |
BUY
Grant, award, or other acquisition
|
Direct |
57,471
+25.88%
|
$1,091,949
$19.14 P/Share
|
Mar 06
2024
|
Sudhakar Varshney SVP, Global Supply Chain |
SELL
Payment of exercise price or tax liability
|
Direct |
1,394
-4.41%
|
$26,486
$19.0 P/Share
|
Mar 06
2024
|
Mojirade James SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,951
-2.67%
|
$37,069
$19.0 P/Share
|
Mar 06
2024
|
Mojirade James SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
30,695
+29.62%
|
$583,205
$19.14 P/Share
|
Mar 06
2024
|
John Joseph Hurley Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
141
-2.08%
|
$2,679
$19.0 P/Share
|
Mar 06
2024
|
John Joseph Hurley Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,829
+21.23%
|
$34,751
$19.14 P/Share
|
Mar 06
2024
|
Joseph Fralin Woody Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,868
-1.98%
|
$168,492
$19.0 P/Share
|
Mar 06
2024
|
Joseph Fralin Woody Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
137,147
+23.48%
|
$2,605,793
$19.14 P/Share
|
Mar 05
2024
|
Kerr Holbrook SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,502
-2.79%
|
$27,036
$18.76 P/Share
|
Mar 05
2024
|
Michael Greiner Interim CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,991
-4.48%
|
$89,838
$18.76 P/Share
|
Mar 05
2024
|
Mojirade James SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,190
-4.93%
|
$39,420
$18.76 P/Share
|
Mar 05
2024
|
Joseph Fralin Woody Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,431
-2.66%
|
$151,758
$18.76 P/Share
|
Mar 05
2024
|
John Joseph Hurley Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
32
-0.68%
|
$576
$18.76 P/Share
|
Jan 03
2024
|
John P Byrnes Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,378
+14.45%
|
-
|
Jan 03
2024
|
Gary Blackford Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,378
+12.33%
|
-
|
Jan 03
2024
|
Julie Ann Shimer Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,378
+14.45%
|
-
|
Jan 03
2024
|
Patrick J Oleary Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,378
+13.29%
|
-
|
Jan 03
2024
|
Lisa Egbuonu Davis Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,378
+37.76%
|
-
|
Dec 11
2023
|
John Joseph Hurley Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
113
-2.35%
|
$2,373
$21.15 P/Share
|
Oct 30
2023
|
John Joseph Hurley Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
562
-10.48%
|
$9,554
$17.81 P/Share
|
Jul 20
2023
|
Mojirade James SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
663
-1.47%
|
$17,238
$26.15 P/Share
|
May 08
2023
|
Michael Greiner Interim CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
14,710
-11.67%
|
$338,330
$23.97 P/Share
|
May 08
2023
|
Kerr Holbrook SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,772
-3.19%
|
$40,756
$23.97 P/Share
|
May 08
2023
|
Joseph Fralin Woody Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
57,256
-15.29%
|
$1,316,888
$23.97 P/Share
|
Mar 06
2023
|
Arjun Ranjan Sarker Senior VP, International |
BUY
Grant, award, or other acquisition
|
Direct |
6,058
+17.65%
|
-
|
Mar 06
2023
|
Mojirade James SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,111
-4.47%
|
$61,219
$29.62 P/Share
|
Mar 06
2023
|
Mojirade James SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
20,339
+30.11%
|
-
|
Mar 06
2023
|
Sudhakar Varshney SVP, Global Supply Chain |
BUY
Grant, award, or other acquisition
|
Direct |
12,463
+28.29%
|
-
|
Mar 06
2023
|
John Joseph Hurley Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
32
-0.59%
|
$928
$29.62 P/Share
|
Mar 06
2023
|
John Joseph Hurley Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,212
+18.35%
|
-
|
Mar 06
2023
|
Michael Greiner Interim CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,037
-2.32%
|
$88,073
$29.62 P/Share
|
Mar 06
2023
|
Michael Greiner Interim CEO |
BUY
Grant, award, or other acquisition
|
Direct |
36,350
+21.75%
|
-
|
Mar 06
2023
|
Joseph Fralin Woody Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,314
-2.17%
|
$241,106
$29.62 P/Share
|
Mar 06
2023
|
Joseph Fralin Woody Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
86,547
+18.44%
|
-
|
Mar 06
2023
|
William David Haydon SVP, GM Pain Franchise |
SELL
Payment of exercise price or tax liability
|
Direct |
1,513
-5.05%
|
$43,877
$29.62 P/Share
|
Mar 06
2023
|
Kerr Holbrook SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,513
-2.65%
|
$43,877
$29.62 P/Share
|